TAGline Fall 2016

October 17, 2016

Maximizing HIV, tuberculosis (TB), and viral hepatitis outcomes depends on the availability of state-of-the-art diagnostic and prognostic tools, engagement in expert and supportive care, and access to safe and effective drugs. Numerous technical barriers to these core components of health and survival exist, such as failures to maintain or improve healthcare infrastructure and capacity building, inadequate funding commitments, bureaucracy and corruption, and corporate rapacity, all of which are priorities for Treatment Action Group and its advocacy partners.

But it’s not simply about advancing good global health policies. It’s also about pushing for good global policies for health, notably those that take aim at the larger social, political, and economic conditions that exacerbate disparities and inequities among those living with, and at risk for, HIV, TB, and viral hepatitis. In this issue of TAGline, several TAG staff members call out some of the most critical social and structural challenges that we continue to face in ending these pandemics.